Marchex (NASDAQ:MCHX - Get Free Report) is projected to release its Q1 2026 results after the market closes on Tuesday, May 12th. Analysts expect Marchex to post earnings of ($0.01) per share and revenue of $10.8890 million for the quarter. Interested persons can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 5:00 PM ET.
Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings results on Wednesday, March 25th. The technology company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.03). The company had revenue of $10.85 million for the quarter, compared to analyst estimates of $10.97 million. Marchex had a negative return on equity of 15.14% and a negative net margin of 11.53%.
Marchex Stock Down 0.3%
Shares of NASDAQ MCHX traded down $0.01 during midday trading on Tuesday, reaching $1.73. 1,383 shares of the stock were exchanged, compared to its average volume of 16,717. The firm has a market cap of $75.74 million, a price-to-earnings ratio of -14.37 and a beta of 1.95. Marchex has a twelve month low of $1.26 and a twelve month high of $2.31. The firm has a 50-day simple moving average of $1.54 and a two-hundred day simple moving average of $1.62.
Institutional Investors Weigh In On Marchex
A number of institutional investors have recently modified their holdings of MCHX. XTX Topco Ltd acquired a new stake in Marchex in the 4th quarter valued at $26,000. Jane Street Group LLC acquired a new stake in Marchex in the 1st quarter valued at $30,000. Manatuck Hill Partners LLC acquired a new stake in Marchex in the 2nd quarter valued at $88,000. Finally, Kanen Wealth Management LLC acquired a new stake in Marchex in the 1st quarter valued at $813,000. 73.46% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on MCHX shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Marchex in a research note on Tuesday, April 21st. Zacks Research raised shares of Marchex from a "strong sell" rating to a "hold" rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Reduce".
View Our Latest Stock Report on MCHX
About Marchex
(
Get Free Report)
Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.
Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marchex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.
While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.